Recommendations on the use of rotavirus vaccines- Rotarix® and RotaTeq® in Singapore

The Health Sciences Authority (HSA) has earlier informed healthcare professionals on the findings of DNA fragments of porcine circovirus 1 (PCV1) in Rotarix® and PCV1 and porcine circovirus 2 (PCV2) DNA fragments in RotaTeq®. HSA, in consultation with the MOH and its Expert Committee on Immunisation (ECI), would like to update healthcare professionals that they can continue to use Rotarix® and RotaTeq® as the benefits of vaccination outweigh the risk of PCV infectivity. Healthcare professionals can continue to use Rotarix® in patients who have previously deferred vaccination. Patients who have started or have been switched to the RotaTeq® vaccination schedule may wish to complete their course of vaccination with RotaTeq®. Parents should be made aware of the presence of the PCV DNA in these vaccines so that they can make an informed decision before their child is vaccinated.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.